Chromadex Corp
Chromadex Corp (ISIN US1710774076) traded at 2.64 € on August 21, 2026. 1 of 1 sharewise users currently rate it a buy; the community's average price target is 3.00 €.
Pros & cons of ChromaDex
Performance of Chromadex Corp vs. its peers
| Security | YTD | 3y |
|---|---|---|
| Chromadex Corp | -52.00% | 89.93% |
| Intellia Therapeutics Inc | 40.92% | -68.32% |
| Cardio3 Biosciences S.A. | 78.52% | -52.93% |
| Arbutus Biopharma Corp. | 10.92% | 135.95% |